Protara Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Protara Therapeutics, Inc. (TARA) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 8.10% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2025-03-05
- Protara Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was 8.10%, a 102.50% increase from fiscal 2023.
- Protara Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was 4.00%.
- Protara Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was 1.50%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month |
|---|---|
| 2024-12-31 | 8.10% 10-K · filed 2025-03-05 |
| 2023-12-31 | 4.00% 10-K · filed 2025-03-05 |
| 2021-12-31 | 1.50% 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |